Clinical trial Recruiting at 1 site Observational Ages 18 and up

Normal Hertel Exophthalmometry Values in Mexican Adults

Official title: Hertel Exophthalmometry Values in Mexican Adults and Their Association With Demographic Factors and Systemic Diseases

Run by Instituto de Oftalmología Fundación Conde de Valenciana · NCT07705061 · Data updated 2026-11-12

This study tests normal Hertel exophthalmometry values in Mexican adults to see how they relate to age, sex, and systemic diseases.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorInstituto de Oftalmología Fundación Conde de Valenciana
Academic / other
Locations1 site (Mexico City, Mexico City)
StatusRecruiting
StartedApril 21, 2026
Main results expectedDecember 28, 2026
Study endsDecember 28, 2026
Registry record updatedJuly 15, 2026
Trial IDNCT07705061 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are Mexican adults aged 18 or older who can undergo bilateral Hertel exophthalmometry and provide informed consent, including those with or without systemic diseases.

Probably not a fit

Patients with active thyroid eye disease or orbital conditions that affect measurements may not benefit from the normative values.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational study in Mexican adults to establish population-specific reference values for Hertel exophthalmometry. Trained examiners will measure globe protrusion using a standardized Hertel exophthalmometer and collect demographic and medical history data. The primary outcome is the distribution of exophthalmometric measurements; secondary analyses explore associations with age, sex, and selected systemic diseases. The results will provide normative values to aid clinical interpretation of orbital assessments in the Mexican population.

Why it matters

Potential benefit: If successful, the study could provide clinicians with tailored reference values to improve detection and assessment of orbital diseases in Mexican adults.

How similar studies have gone: Similar efforts have established population-specific normative data for exophthalmometry in other groups, supporting the feasibility of this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years or older.
* Mexican participants or individuals who self-identify as Mexican.
* Ability to understand the study procedures and provide written informed consent.
* Ability to undergo bilateral Hertel exophthalmometry.
* Participants with or without previously diagnosed systemic diseases.

Exclusion Criteria:

* Active thyroid eye disease
* History of orbital trauma or orbital fracture.
* Previous orbital surgery, orbital decompression, or surgery that may alter globe position.
* Presence or history of an orbital tumor, orbital inflammation, or orbital infection.
* Craniofacial abnormalities or facial asymmetry that may interfere with Hertel exophthalmometry.
* Ocular or eyelid conditions that prevent accurate positioning or measurement with the Hertel exophthalmometer.
* Inability to cooperate with the examination or obtain a reliable exophthalmometry measurement.

Where it's running

  • ✔ Instituto de Oftalmología Fundación Conde de Valenciana IAP
    Mexico City, Mexico City, Mexico
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.